Articles about Athira Pharma

Athira Pharma recovers from Alzheimer’s failure with breast cancer pivot and $90M investment

In a remarkable pivot, Athira Pharma has a deal to test a promising breast cancer drug and landed $90 million in upfront funding from investors. Read More

Tech Moves: Microsoft vet named CEO at EnterpriseDB; Adaptive CCO departs; Temporal hires ex-Hashicorp EVP

— Kevin Dallas, a longtime Seattle-area tech and finance executive, was named CEO and board member of Bedford, Mass.-based enterprise… Read More

Athira Pharma shares drop nearly 70% on release of clinical trial data for Alzheimer’s disease

Athira Pharma’s stock plummeted nearly 70% Wednesday after a clinical trial testing its candidate drug for Alzheimer’s disease failed to… Read More

Life sciences news: Seagen CEO resigns after arrest, cautious optimism for biotech, and more

Here’s a rundown of the top life sciences and health news across the Pacific Northwest this week. Seagen CEO resigns… Read More

Investor who called for ouster of Athira Pharma CEO suspends campaign

The activist shareholder behind an attempt to replace the CEO of Athira Pharma has suspended his campaign. Billionaire Richard (Ric)… Read More

Former Athira Pharma exec says company fell below ‘scientific ethics’ in handling of ex-CEO

The former head of clinical development and research at Athira Pharma criticized the company’s handling of an investigation that led… Read More

Latest life sciences news: COVID-19 nasal spray; disease reversal; Amazon’s healthcare priorities

This week we highlighted the finalists for Health Innovation of the Year at the GeekWire Awards. The finalists showcase the… Read More

Latest drama at Athira: Investor calls for CEO replacement and wants two board seats

A billionaire investor of Athira Pharma is calling for the ouster of the Seattle company’s CEO and nominated himself and… Read More

Tech Moves: Adaptive Biotechnologies’ chief medical officer resigns; Athira Pharma’s new hires

— Lance Baldo stepped down as chief medical officer of Adaptive Biotechnologies. Baldo is “moving on to pursue another professional… Read More

Ex-Athira Pharma CEO Leen Kawas starts $150M fund with key investors from former company

Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered… Read More

Internal memo: Ex-Athira CEO says ‘I should have known better’ after image manipulation investigation

The former CEO of Athira Pharma wrote a letter of contrition addressed to employees on Thursday, after resigning in the… Read More

Ex-Athira Pharma CEO Leen Kawas resigns and leaves board after image manipulation investigation

Leen Kawas has formally resigned as CEO and president of Athira Pharma and is stepping off the board after an… Read More

Tech Moves: Top Blue Origin engineer joins SpaceX; Axon hires HTC Vive exec; Porch adds to board

— Law enforcement technology company Axon added former HTC Vive exec Chris Chin as vice president of immersive tech. In… Read More

Athira Pharma extends Alzheimer’s clinical trial, adds new execs after CEO placed on leave

Athira Pharma is advancing its clinical trials in the wake of allegations of image manipulation in papers authored by its… Read More

Tech Moves: The Riveter’s Amy Nelson to lead new SaksWorks venture; Funko’s leadership transition

— Amy Nelson is getting back into co-working. The founder and former CEO of The Riveter announced Tuesday that she… Read More

Biotech firm Athira Pharma hit by class action lawsuits following image manipulation claims

The lawsuits have begun. Barely a week after the CEO of Athira Pharma was placed on temporary leave after allegations… Read More

Athira Pharma CEO Leen Kawas placed on leave, shares sink more than 30%

Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review… Read More

Approval of Biogen’s drug for Alzheimer’s disease may ease path for others such as Athira Pharma

The approval on Monday of the first new drug for Alzheimer’s disease in nearly two decades — Biogen’s aducanumab —… Read More

IPOs: A hot year for tech offerings shows deep economic disparities

In a year when large swaths of the economy sputtered due to the pandemic, Wall Street opened its doors to… Read More

Podcast

2021 Predictions: Why these tech, science and startup leaders are upbeat about the year ahead

An “incredibly dynamic year of change,” a “new hope,” and a “gangbusters” year in which the tech sector will come… Read More

Athira Pharma wins $15M grant from National Institute on Aging for trial of Alzheimer’s drug

Seattle-based biotech company Athira Pharma announced a three-year grant totaling $15 million from the National Institute on Aging to support… Read More

Athira Pharma raises $204M in IPO, reaching ‘big milestone’ in fight against Alzheimer’s and other diseases

More than 5 million Americans have Alzheimer’s disease, and the number is projected to rise to nearly 14 million by… Read More

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

Athira Pharma will raise at least $204 million as the Seattle biotech startup becomes a public company on Friday. Athira… Read More

Seattle biotech Athira Pharma sets terms for IPO, aims to raise up to $170M

Athira Pharma plans to price its stock at $15 to $17 per share and raise up to $170 million in… Read More

Podcast

GeekWire Podcast: Breaking the IPO glass ceiling; Who succeeds Bezos?; TikTok’s ticking clock

Here’s what we’re talking about on the GeekWire Podcast this week. When Athira Pharma filed with the Nasdaq for a… Read More

This 35-year-old female CEO is about to crack the glass ceiling, shattering a dismal IPO track record

Leen Kawas is truly a unicorn. The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the… Read More

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

Athira Pharma is aiming to go public. The Seattle biotech filed initial IPO paperwork Wednesday, a surprising move that would… Read More

Seattle biotech startup Athira raises $85M to develop therapies for Alzheimer’s and Parkinson’s

The foundation of Athira Pharma began while Leen Kawas was earning her Ph.D. in molecular pharmacology at Washington State University nearly… Read More

Vote for Health Innovation of the Year: Tech and life sciences unite at the 2020 GeekWire Awards

Editor’s note: The GeekWire Awards are now virtual on July 23. Watch live below. Technology is increasingly influencing the science… Read More

Tech Moves: T-Mobile’s TV lead departs; Madrona Venture Labs adds Seattle startup marketing vet; and more

— T-Mobile‘s head of home and entertainment, Jeffrey Binder, has left the company. Binder was the CEO of television technology… Read More